Latest Breaking News On - Unicycive therapeutics - Page 1 : comparemela.com

Unicycive Therapeutics (UNCY) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Unicycive Therapeutics (NASDAQ:UNCY – Free Report) in a report issued on Wednesday, Benzinga reports. The brokerage currently has a $4.50 price objective on the stock. Several other brokerages have also recently commented on UNCY. Noble Financial started coverage on Unicycive Therapeutics in a research report on […]

United statesPiper sandlerUnicycive therapeutics company profileVivo capitalVirtu financialRosalind advisors incUnicycive therapeutics incUnicycive therapeuticsFree reportGet free reportUnicycive therapeutics daily

HC Wainwright Reiterates Buy Rating for Unicycive Therapeutics (NASDAQ:UNCY)

Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They presently have a $4.50 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 437.76% from the stock’s previous close. A number of […]

United statesPiper sandlerVivo capitalVirtu financialRosalind advisors incUnicycive therapeutics incUnicycive therapeutics company profileUnicycive therapeuticsGet free reportNoble financialUnicycive therapeutics daily

Unicycive Therapeutics (UNCY) Buy Rating Reiterated at HC Wainwright

Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $4.50 price target on the stock. HC Wainwright’s price objective points to a potential upside of 437.76% from the […]

United statesPiper sandlerVirtu financialVivo capitalUnicycive therapeutics incRosalind advisors incUnicycive therapeuticsGet free reportUnicycive therapeutics daily

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY)

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSatya medicherlaShalabh guptaEuropean renal associationShire international licensingUnicycive therapeutics incReason researchExchange commissionCompany or unicyciveMoral administrationDrug administrationRenal associatesPreclinical modelHyperphosphatemia demonstrateRelative potency

Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference

Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Shalabh guptaUnicycive therapeutics incCompany or unicyciveUnicycive therapeuticsChief executive officerFireside chatLytham partners spring